(No ratings)
Dr. Daniel Aaron Crawford, MD is a radiologist in Scottsdale, AZ specializing in interventional radiology/diagnostic radiology (ir/dr). He graduated from University of Arizona College of Medicine in 2018 and has 8 years of experience. Dr. Daniel Aaron Crawford, MD is affiliated with Mayo Clinic and MAYO CLINIC ARIZONA.
Benign Prostatic Hyperplasia (Enlarged Prostate)
Benign prostatic hyperplasia (BPH) is a noncancerous condition in which the prostate gland becomes enlarged. BPH affects about half of men between the ages of 50 and 60, and approximately 80% of men over 80. As the prostate grows in size, it can press down on the tube where urine flows out of the body (the urethra) and cause urinary problems.
Medication can relieve mild to moderate symptoms of BPH, such as frequent urination, incomplete bladder emptying, a weak urine stream, and straining while urinating. However, other forms of treatment may be more appropriate if an individual has pain with urination, frequent urinary tract infections, or is unable to urinate. The size of the prostate and the severity of their symptoms will determine the type of treatment they need. If the prostate is not very large, doctors will likely recommend a transurethral procedure. This minimally invasive technique involves the insertion of a scope into the urethra. The most common transurethral procedures for BPH are:
If the prostate is too big for a transurethral procedure, an individual may need a simple prostatectomy, which can be done in one of three ways: laparoscopic, robotic, or open. During a laparoscopic simple prostatectomy, a surgeon makes several small incisions on the belly. Then they insert a long tube with a camera into one of the cuts and surgical instruments into the others. Using the camera to see inside the belly, they carefully removes the enlarged part of the prostate. Robotic simple prostatectomy uses the same techniques as the laparoscopic method, but the surgery is done with the help of a robot. For men with very large prostates, open simple prostatectomy may be the best treatment option. This surgery differs from the other approaches in that it requires a much larger incision.
Most transurethral treatments for BPH, like TUIP, TUNA, and laser prostate ablation, are done in the doctor's office or outpatient surgery center. TURP and simple prostatectomy, however, need to be performed in the hospital and require an average stay of one to three days. Patients should wait a week before doing any strenuous activities after a TUIP, TUNA, or laser prostate ablation, and about four to six weeks after a TURP or simple prostatectomy. Although these treatments improve BPH symptoms for most patients, it is important to be aware of the risks involved, such as urine control issues, tightening of the urethra, and erectile dysfunction.
Radioembolization (Selective Internal Radiation Therapy)
Radioembolization, or selective internal radiation therapy (SIRT), is a minimally invasive procedure that uses radiation to treat liver tumors. By targeting the hepatic artery, or the main blood vessel that supplies the liver, radioembolization can cut off the blood supply to liver tumors. The tumors shrink, and minimal damage is done to healthy tissue. Radioembolization is a treatment option for tumors that cannot be removed by surgery or other radiation therapies, for liver cancer that is confined to the liver, or for liver cancer patients that have more than 3 months of life expectancy.
To perform radioembolization, a catheter is inserted into an artery in the groin and threaded to the liver. Radioactive beads, or pellets, are delivered through the catheter. The pellets will continuously deliver radiation for 10-14 days. The pellets will remain in the body permanently without causing any complications. If the tumor or cancer is confined to one portion of the liver, radioembolization will be performed in one treatment session. If both sides of the liver are affected, a second treatment session will be done about 8 weeks after the first.
Typically, most patients can return home and do light activity within hours following the procedure. Patients will be given medication to treat any possible side effects, which can include nausea, fever, abdominal pain, or tiredness.
Dr. Daniel Aaron Crawford, MD graduated from University of Arizona College of Medicine in 2018. He completed residency at Mallinckrodt Institute of Radiology. He has a state license in Arizona.
Medical School: University of Arizona College of Medicine (2018)
Residency: Mallinckrodt Institute of Radiology (2024)
Licensed In: Arizona
Dr. Daniel Aaron Crawford, MD is associated with these hospitals and organizations:
Dr. Daniel Aaron Crawford, MD does not have any reviews yet, be the first to leave a review of Dr. Daniel Aaron Crawford, MD here: Leave a Review
(No ratings)
Dr. Daniel Crawford practices interventional radiology/diagnostic radiology (IR/DR). Clinical interests for Dr. Crawford include portal hypertension, radioembolization (selective internal radiation therapy), and benign prostatic hyperplasia (enlarged prostate). He studied medicine at the University of Arizona College of Medicine. His training includes a residency program at Mallinckrodt Institute of Radiology. He has received the following distinctions: Gold Humanism Honor Society - University of Arizona College of Medicine; Summa Cum Laude - University of Arizona; and Most Outstanding Senior in Engineering Award - University of Arizona. He is affiliated with Mayo Clinic.